Sarepta Therapeutics Inc. (0L35)
Market Closed
20 Jul, 15:30
$
17. 15
-0.14
-0.8097%
$
- Market Cap
- P/E Ratio
- Div Yield
1,799 Volume
-6.99 Eps
$ 17.29
Previous Close Want to track 0L35 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sarepta Therapeutics Inc. (0L35) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.39B
Trailing P/E (ttm) 27.77
Forward P/E -
PEG ratio 0.06
Price/Sales (ttm) 0.83
Price/Book (mrq) 1.2
Enterprise Value/Revenue 1.09
Enterprise Value/EBITDA 19.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.1K
Average volume (90 days) 7.95K
Price summary
52-Week low 10.48
52-Week high 25.34
Beta -
50-Day moving average 17.35
200-Day moving average 19.1
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 12 Jul 2012
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.03%
Operating margin -0.02%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.05%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 20.8
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.62
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.22
Total debt (mrq) -
Total Debt/Equity (mrq) 0.69
Current ratio (mrq) 4.63%
Book value per share (mrq) 14.34
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
